The SUSTAIN-6 trial demonstrated that Ozempic significantly reduces the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes and established cardiovascular disease
These medications work by influencing appetite regulation and metabolic pathways
These medications offer sustained weight loss benefits, making them valuable options for those with obesity or looking to shed excess body weight
References to Wegovy, Ozempic, Rybelsus, Mounjaro, or Saxenda, or other GLP-1 brands, are informational only
Regular thyroid function monitoring is advisable during treatment
Luckily, there are plenty of steps you can take to feel better, including minimizing fatty foods, eating more slowly, and trying nausea medication